gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · AORTHealthcareSurgical Instruments

Artivion, Inc. (AORT)

$26.45+11.56%
Close Nov 4, 2026 · split-adjusted
Nov 2, 2026$23.58▼ 48.39% in range
Nov 3, 2025Low $20.10 · High $47.63Nov 2, 2026
What changed · written from our data
As of Nov 4, 2026

Artivion closed at $26.45 on Nov 4, up 11.56%, 44.5% below its 52-week closing high. Volume of 1.1M shares was 2.20× its 20-day average (well above normal).

Split-adjusted performance: +21.1% over one month, -23.8% over six months, -42.1% over one year.

In the quarter ended Jun 30, 2026, revenue was $125.76M, up 11.3% from a year earlier, with a net margin of -10.7%.

Short interest was 3.7M shares at the Oct 15 settlement, up 3.1% from the prior report (8.2% of float, 7.2 days to cover).

Market cap$1.29B48.8M shares
Revenue · quarter$125.8M+11.3% YoY
Diluted EPS$-0.28−1033.3% YoY
P/E · TTM—P/S 2.7×
Net margin-10.7%Gross 64.0%
Dividend yieldNone
52-week range20.10 – 47.63−44.5% from high
Volume1.1M2.20× 20-day avg
Volatility · 60d41.1%Annualised
Short % of float8.2%7.2 days to cover
Net cash-$296.3MCash $77.3M
Next earnings—Not scheduled
Split-adjusted performance
1W +15.4%1M +21.1%3M −0.5%6M −23.8%YTD −42.0%1Y −42.1%3Y +110.1%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum34
Revenue growth55
Net margin46
Value (low P/E)—
Size73

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short3.7M+3.1% vs prior
Days to cover7.2Settled Oct 15
% of float8.2%
Short vol. 10d58.8%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
AORTArtivion$26.45+11.56%−23.8%+11.3%−10.7%—$1.29B
ATECAlphatec Holdings$8.28+10.84%+18.5%+12.6%−2.5%—$1.27BCompare
TNDMTandem Diabetes Care$19.05+7.93%+5.7%+5.8%−8.3%—$1.33BCompare
PRCTPROCEPT BioRobotics$21.66+7.39%−12.7%+19.3%−28.4%—$1.24BCompare
IARTIntegra LifeSciences$14.82+8.73%+5.9%+2.3%3.6%88.6$1.15BCompare
SGPSpyGlass Pharma$34.450.00%+37.5%———$1.15BCompare
IRMDiRadimed$88.58+9.21%+2.7%+14.2%26.9%47.2$1.13BCompare
SIBNSI-BONE$24.95+4.96%+92.1%+15.2%−7.3%—$1.12BCompare
NVCRNovoCure Limited$14.61+8.79%−11.4%+15.7%−5.4%—$1.71BCompare

News about Artivion

All news →
Crafting title options within editorial guidelines An ETF Shop Just Made a Beaten-Down Medtech Its Top HoldingThe Motley Fool · May 17, 2026Neutral

Quick answers

What does Artivion do?
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
What is AORT's market cap?
$1.29B, based on the Nov 4 close of $26.45.
Does Artivion pay a dividend?
No regular cash dividend has been paid in the last year.
How much of AORT is sold short?
3.7M shares, 8.2% of float, as of Oct 15, 2026.
What sector is AORT in?
Healthcare, in the Surgical Instruments industry.

About Artivion

Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.

HQ: Kennesaw, GA1,800 employeesListed Feb 11, 1993artivion.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology